Table 2 Clinical characteristics of 14 CRC patients included in the study.
From: PTPN11 is a potential biomarker for type 2 diabetes mellitus complicated with colorectal cancer
Variable | Nondiabetic (n = 8) | Diabetic (n = 6) | P-value |
|---|---|---|---|
Age (years, mean ± SD) | 58.13 ± 17.34 | 65.83 ± 14.85 | 0.400 |
Sex | Â | Â | 0.580 |
 Male | 5(62.50%) | 5(83.33%) |  |
 Female | 3(37.50%) | 1(16.67%) |  |
BMI (kg/m2, mean ± SD) | 22.85 ± 1.49 | 24.24 ± 1.54 | 0.117 |
FBG (mmol/l, mean ± SD) | 5.30 ± 0.28 | 7.50 ± 1.03 | < 0.001 |
Location | Â | Â | 0.538 |
 Colon | 7(87.50%) | 4(66.67%) |  |
 Rectum | 1(12.50%) | 2(33.33%) |  |
Pathological Differentiation [n (%)] |  |  | – |
 Moderate | 8(100.00%) | 6(100.00%) |  |
Pathological T category [n (%)] | Â | Â | 0.085 |
 T1 | – | 1(16.67%) |  |
 T3 | 4(50.00%) | 5(86.33%) |  |
 T4 | 4(50.00%) | 0 |  |
Pathological N category [n (%)] | Â | Â | 0.277 |
 N0 | 5(62.50%) | 2(33.33%) |  |
 N1 | 2(25.00%) | 4(66.67%) |  |
 N2 | 1(12.50%) | – |  |
pTNM stage [n (%)] | Â | Â | 0.172 |
 I | – | 1(16.67%) |  |
 II | 5(62.50%) | 1(16.67%) |  |
 III | 3(37.50%) | 4(66.67%) |  |
